Lab Automation In-Depth Focus 2019
Posted: 18 March 2019 | Drug Target Review | No comments yet
In this In-Depth Focus: realising the promise of laboratory automation in biomedical research, drug discovery from the age of information to the age of intelligence, and transforming drug discovery, development and delivery with flow chemistry.
Included in this In-Depth Focus:
- Realising the promise of laboratory automation in biomedical research
Pushpanathan Muthuirulan explores laboratory automation in biomedical research, highlighting how it offers versatile platforms to perform tasks quickly and free from human errors. He discusses how automated techniques have been used in genomics workflows, molecular diagnostics and clinical microbiology to ensure reproducibility, enhancing the productivity of the research. - Drug discovery from the age of information to the age of intelligence
Data drives drug discovery, yet it continues to be among the biggest challenges faced by the industry. Jeff Martin discusses what is needed in order to help avoid this, he explains that it is imperative that decisions are made from the most accurate representation of science; otherwise the risks of failure only increase. Evolving technology presents many opportunities to not only reverse the tides, but to leverage data with unprecedented benefits. - Transforming drug discovery, development and delivery with flow chemistry
Flow chemistry is on the rise thanks to the commercial availability of benchtop continuous flow systems that has driven widespread adoption of the technique across a broad range of applications in both academia and industry. Nicola Tirelli and Omar Jina discuss how flow chemistry is delivering significant benefits in the area of drug discovery and development by enabling chemistry to be performed that is not currently achievable using traditional techniques.
Related topics
Artificial Intelligence, Drug Discovery, Lab Automation
Related people
Jeff Martin, Nicola Tirelli, Omar Jina, Pushpanathan Muthuirulan
